These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8011844)

  • 1. Serum adenosine deaminase levels in intravenous drug users with and without infection due to human immunodeficiency virus.
    Iñigo MA; López de Tejada MR; Torres-Tortosa M; Sánchez-Porto A
    Clin Infect Dis; 1994 Mar; 18(3):478-9. PubMed ID: 8011844
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic value of adenosine deaminase compared to other markers for progression to acquired immunodeficiency syndrome among intravenous drug users.
    Casoli C; Lisa A; Magnani G; Starcich R; Fiaccadori F; Bertazzoni U; Zei G
    J Med Virol; 1995 Feb; 45(2):203-10. PubMed ID: 7775940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serum adenosine deaminase in human immunodeficiency virus infection. Its relationship with CD4+ lymphocytes and beta 2-microglobulin].
    Iñigo MA; Ruiz López de Tejada M; Torres-Tortosa M; Sánchez-Porto A; Ugarte I; García de Lomas E; Morán Nestares A
    Med Clin (Barc); 1992 Dec; 99(20):766-8. PubMed ID: 1361013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum adenosine deaminase 2 and neopterin levels are increased in a majority of hemophiliacs irrespective of infection with human immunodeficiency virus type 1.
    Matsuda J; Tsukamoto M; Gohchi K; Saitoh N; Kawasugi K; Kinoshita T
    Clin Infect Dis; 1993 Feb; 16(2):260-4. PubMed ID: 8443304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine deaminase, acquired immunodeficiency syndrome (AIDS), and hepatitis B infection.
    Martínez-Hernández D; Arenas Barbero J; Jaqueti Aroca J; Pérez-Piqueras FJ; Santos Sancho J; Cosín Ochaitia J; Gómez de Terreros FJ
    Clin Chem; 1992 Jan; 38(1):162-3. PubMed ID: 1733592
    [No Abstract]   [Full Text] [Related]  

  • 6. S-adenosylhomocysteine hydrolase activity in erythrocytes from HIV-infected patients.
    Bozzi A; Leonardi F; De Rinaldis ML; Ferrazzi M; Strom R
    Adv Exp Med Biol; 1991; 309B():213-7. PubMed ID: 1781371
    [No Abstract]   [Full Text] [Related]  

  • 7. [Serum adenosine deaminase and hepatitis C virus infection].
    Fernández E; Riestra S; Rodríguez S; Rodríguez M
    Med Clin (Barc); 1995 Feb; 104(4):158. PubMed ID: 7898166
    [No Abstract]   [Full Text] [Related]  

  • 8. [An esophageal ulcer due to cytomegalovirus in a female patient infected with the human immunodeficiency virus without serious immunosuppression: is this an acquired immunodeficiency syndrome?].
    Soriano V; Gutiérrez M; García-Samaniego J; González-Lahoz J
    Med Clin (Barc); 1992 May; 98(18):717-8. PubMed ID: 1318483
    [No Abstract]   [Full Text] [Related]  

  • 9. [AIDS and HIV infection in intravenous drug addicts in the Federal Republic of Germany].
    Stark K; Kleiber D
    Dtsch Med Wochenschr; 1991 May; 116(22):863-9. PubMed ID: 2036946
    [No Abstract]   [Full Text] [Related]  

  • 10. Adenosine deaminase isoenzymes and HIV/HTLV-1 infections.
    Yokoyama MM; Tsuboi I
    J Natl Cancer Inst; 1988 Jul; 80(9):698. PubMed ID: 2897474
    [No Abstract]   [Full Text] [Related]  

  • 11. Human T-cell lymphotropic virus type I disease in Argentine intravenous drug users with human immunodeficiency virus type 1 infection.
    Zala C; Zapiola I; Bouzas MB; Benetucci J; Lopez L; Gallo D; Hanson C; Muchinik GR
    J Acquir Immune Defic Syndr (1988); 1994 Aug; 7(8):870-1. PubMed ID: 8021821
    [No Abstract]   [Full Text] [Related]  

  • 12. Zidovudine treatment increases erythrocyte adenosine deaminase activity.
    Palomba E; David O; Gabiano C; Pescarmona GP; Tovo PA
    AIDS; 1991 May; 5(5):603-4. PubMed ID: 1863416
    [No Abstract]   [Full Text] [Related]  

  • 13. Lessons from the history of the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic among Spanish drug injectors.
    De La Fuente L; Bravo MJ; Barrio G; Parras F; Suárez M; Rodés A; Noguer I
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S410-5. PubMed ID: 14648456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Should Hodgkin's disease be considered a diagnostic criterion of AIDS?].
    Pintado V; Valencia E; Lavilla P; López-Dupla M; Gil A
    Rev Clin Esp; 1992 Jun; 191(1):50. PubMed ID: 1631363
    [No Abstract]   [Full Text] [Related]  

  • 15. Universal access to HIV/AIDS treatment for injecting drug users: keeping the promise.
    Ball AL
    Int J Drug Policy; 2007 Aug; 18(4):241-5. PubMed ID: 17689371
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection.
    Selwyn PA; Alcabes P; Hartel D; Buono D; Schoenbaum EE; Klein RS; Davenny K; Friedland GH
    N Engl J Med; 1992 Dec; 327(24):1697-703. PubMed ID: 1359411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perspectives on infection with HIV-1 among intravenous drug users.
    Vlahov D; Polk BF
    Psychopharmacol Bull; 1988; 24(3):325-9. PubMed ID: 3153487
    [No Abstract]   [Full Text] [Related]  

  • 18. Human immunodeficiency virus-related morbidity and mortality in injection drug users: should the AIDS definition be changed yet again?
    Royce R
    Epidemiology; 1996 Nov; 7(6):563-5. PubMed ID: 8899379
    [No Abstract]   [Full Text] [Related]  

  • 19. AIDS behind bars: preventing HIV spread among incarcerated drug injectors.
    Dolan K; Wodak A; Penny R
    AIDS; 1995 Aug; 9(8):825-32. PubMed ID: 7576315
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum adenosine deaminase activity in HIV positive subjects. A hypothesis on the significance of ADA2.
    Gakis C; Calia G; Naitana A; Pirino D; Serru G
    Panminerva Med; 1989; 31(3):107-13. PubMed ID: 2689968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.